Report Detail
Global Leukocyte Surface Antigen CD47 Market Insights, Forecast to 2025
- RnM2910832 |
- 19 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Leukocyte Surface Antigen CD47 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Leukocyte Surface Antigen CD47 market based on company, product type, end user and key regions.
This report studies the global market size of Leukocyte Surface Antigen CD47 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Leukocyte Surface Antigen CD47 in these regions.
This research report categorizes the global Leukocyte Surface Antigen CD47 market by top players/brands, region, type and end user. This report also studies the global Leukocyte Surface Antigen CD47 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Market size by Product
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Market size by End User
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Leukocyte Surface Antigen CD47 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Leukocyte Surface Antigen CD47 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Leukocyte Surface Antigen CD47 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Leukocyte Surface Antigen CD47 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Leukocyte Surface Antigen CD47 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Leukocyte Surface Antigen CD47 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Leukocyte Surface Antigen CD47 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Product
- 1.4.2 B-6H12
- 1.4.3 ALX-148
- 1.4.4 CC-90002
- 1.4.5 PSTx-23
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by End User
- 1.5.2 Lymphoma
- 1.5.3 Ovarian Cancer
- 1.5.4 Ischemia Reperfusion Injury
- 1.5.5 Kindney Transplant Rejection
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Leukocyte Surface Antigen CD47 Market Size
- 2.1.1 Global Leukocyte Surface Antigen CD47 Revenue 2014-2025
- 2.1.2 Global Leukocyte Surface Antigen CD47 Sales 2014-2025
- 2.2 Leukocyte Surface Antigen CD47 Growth Rate by Regions
- 2.2.1 Global Leukocyte Surface Antigen CD47 Sales by Regions
- 2.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Leukocyte Surface Antigen CD47 Sales by Manufacturers
- 3.1.1 Leukocyte Surface Antigen CD47 Sales by Manufacturers
- 3.1.2 Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers
- 3.1.3 Global Leukocyte Surface Antigen CD47 Market Concentration Ratio (CR5 and HHI)
- 3.2 Leukocyte Surface Antigen CD47 Revenue by Manufacturers
- 3.2.1 Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2014-2019)
- 3.2.2 Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2014-2019)
- 3.3 Leukocyte Surface Antigen CD47 Price by Manufacturers
- 3.4 Leukocyte Surface Antigen CD47 Manufacturing Base Distribution, Product Types
- 3.4.1 Leukocyte Surface Antigen CD47 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Leukocyte Surface Antigen CD47 Product Type
- 3.4.3 Date of International Manufacturers Enter into Leukocyte Surface Antigen CD47 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Leukocyte Surface Antigen CD47 Sales by Product
- 4.2 Global Leukocyte Surface Antigen CD47 Revenue by Product
- 4.3 Leukocyte Surface Antigen CD47 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Leukocyte Surface Antigen CD47 Breakdown Data by End User
6 North America
- 6.1 North America Leukocyte Surface Antigen CD47 by Countries
- 6.1.1 North America Leukocyte Surface Antigen CD47 Sales by Countries
- 6.1.2 North America Leukocyte Surface Antigen CD47 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Leukocyte Surface Antigen CD47 by Product
- 6.3 North America Leukocyte Surface Antigen CD47 by End User
7 Europe
- 7.1 Europe Leukocyte Surface Antigen CD47 by Countries
- 7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Countries
- 7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Leukocyte Surface Antigen CD47 by Product
- 7.3 Europe Leukocyte Surface Antigen CD47 by End User
8 Asia Pacific
- 8.1 Asia Pacific Leukocyte Surface Antigen CD47 by Countries
- 8.1.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Countries
- 8.1.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Leukocyte Surface Antigen CD47 by Product
- 8.3 Asia Pacific Leukocyte Surface Antigen CD47 by End User
9 Central & South America
- 9.1 Central & South America Leukocyte Surface Antigen CD47 by Countries
- 9.1.1 Central & South America Leukocyte Surface Antigen CD47 Sales by Countries
- 9.1.2 Central & South America Leukocyte Surface Antigen CD47 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Leukocyte Surface Antigen CD47 by Product
- 9.3 Central & South America Leukocyte Surface Antigen CD47 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Leukocyte Surface Antigen CD47 by Countries
- 10.1.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Countries
- 10.1.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Leukocyte Surface Antigen CD47 by Product
- 10.3 Middle East and Africa Leukocyte Surface Antigen CD47 by End User
11 Company Profiles
- 11.1 Aurigene Discovery Technologies Ltd
- 11.1.1 Aurigene Discovery Technologies Ltd Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Products Offered
- 11.1.5 Aurigene Discovery Technologies Ltd Recent Development
- 11.2 Celgene Corp
- 11.2.1 Celgene Corp Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Products Offered
- 11.2.5 Celgene Corp Recent Development
- 11.3 Forty Seven Inc
- 11.3.1 Forty Seven Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Products Offered
- 11.3.5 Forty Seven Inc Recent Development
- 11.4 Surface Oncology Inc
- 11.4.1 Surface Oncology Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Products Offered
- 11.4.5 Surface Oncology Inc Recent Development
- 11.5 Trillium Therapeutics Inc
- 11.5.1 Trillium Therapeutics Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Products Offered
- 11.5.5 Trillium Therapeutics Inc Recent Development
12 Future Forecast
- 12.1 Leukocyte Surface Antigen CD47 Market Forecast by Regions
- 12.1.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Regions 2019-2025
- 12.2 Leukocyte Surface Antigen CD47 Market Forecast by Product
- 12.2.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Product 2019-2025
- 12.2.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Product 2019-2025
- 12.3 Leukocyte Surface Antigen CD47 Market Forecast by End User
- 12.4 North America Leukocyte Surface Antigen CD47 Forecast
- 12.5 Europe Leukocyte Surface Antigen CD47 Forecast
- 12.6 Asia Pacific Leukocyte Surface Antigen CD47 Forecast
- 12.7 Central & South America Leukocyte Surface Antigen CD47 Forecast
- 12.8 Middle East and Africa Leukocyte Surface Antigen CD47 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Leukocyte Surface Antigen CD47 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Leukocyte Surface Antigen CD47 . Industry analysis & Market Report on Leukocyte Surface Antigen CD47 is a syndicated market report, published as Global Leukocyte Surface Antigen CD47 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Leukocyte Surface Antigen CD47 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
